
Kevin John John, MD MRCP
@drkevinjj
Internal Medicine | Tufts Medical Center, Boston | CMC Vellore alumnus | Formula One fan | My tweets are my own.
ID: 812202772774854657
23-12-2016 07:46:45
170 Tweet
432 Followers
444 Following


'SCAI-walking' patient trajectories shows why stage B is Bad! Congratulations to Khue Ton Elric Zweck Navin Kapur Manreet Kanwar Jaime Hernandez-Montfort Song Li and team for this effort! jacc.org/doi/10.1016/j.… Check out the CSWG-SCAI Walker app to 'SCAI-walk' your patients!


Another tremendous piece from the #CardiogenicShockWorkingGroup by #WissamKhalife, @manreetkanwar, & Navin Kapur - authors.elsevier.com/c/1juoV3pkRzhd…. Jacob Abraham, MD Song Li Kevin John John, MD MRCP Shashank Sinha, MD, MSc, FACC, FAHA, FHFSA Elric Zweck A. Reshad Garan MD Jaime Hernandez-Montfort Khue Ton Maya Guglin Dr. Claudius Mahr, FACC, FESC, FRSM 4/


Wonderful talk by Song Li on role of ML/AI in CS care and research Shashank Sinha, MD, MSc, FACC, FAHA, FHFSA Rachna Kataria, MD Sandeep Nathan, MD, MSc Perwaiz Meraj Jacob Abraham, MD Navin Kapur Manreet Kanwar Jaime Hernandez-Montfort Kevin John John, MD MRCP


Out now in Circulation: an in-depth analysis of #renal risk factors and outcomes in the #DanGer #shock trial. Led by pioneer #JacobEMoller. Accompanied by an excellent editorial by Saraschandra Vallabhajosyula, MD MSc. Christian Hassager Ralf Westenfeld Amin Polzin doi.org/10.1161/CIRCUL…

Really happy to share that our review and analysis of ongoing clinical trials of ADCs for patients with breast cancer brain metastases is out now! Ilana Schlam Dr Sarah Sammons Nancy Lin, MD Paolo Tarantino Sara Tolaney Aditya Bardia, MD A thread of salient points & ideas of this article 🧵:

Excited to share our #CSWG analysis on pRVAD use in Cardiogenic Shock, focussed on ProtekDuo and Impella RP! Grateful for the mentorship of Navin Kapur, Jaime Hernandez-Montfort, @manreetkanwar, Song Li et al. shorturl.at/KZoyv

Honored to join this incredible group! Grateful for the unwavering support and guidance from my mentors at Tufts Medical Center and the #CSWG family!! Navin Kapur @manreetkanwar Jaime Hernandez-Montfort Shashank Sinha, MD, MSc, FACC, FAHA, FHFSA Arvind Bhimaraj A. Reshad Garan MD Jacob Abraham, MD Dan Burkhoff MD PhD Ajar Kochar


Gracias por inspirarnos, colaborar y ayudarnos a crecer en el entendimiento de choque cardiogenico en 🇲🇽 - LATAM #CSWG Alexandra Arias Guillermo Torre Vicente Jimenez-Franco MD 🇲🇽🫀 Jorge A Ortega Hdz, FESC I. N. Cardiología Mx TecSalud - Sistema de Salud del Tec de Monterrey Navin Kapur



I’m honored to soon be serving on the steering committee of the CSWG alongside my fellow #cardiogenic #shock warriors, following the vision and leadership of Navin Kapur Dan Burkhoff MD PhD Manreet Kanwar Jaime Hernandez-Montfort Shashank Sinha, MD, MSc, FACC, FAHA, FHFSA and A. Reshad Garan MD

Congratulations to Navin Kapur on 🔟 years of CSWG 🫶🏻⚡️ We see lots of ⚡️ at Tufts & are lucky to have the opportunity to learn from attendings like Navin both clinically & academically. (PS in addition to furthering our knowledge, Navin ensures we are well fed. #priorities)


Dr. Navin Kapur is a 2025 Boston Business Journal Innovators in Healthcare honoree! Dr. Kapur leads Tufts MC's CardioVascular Center for Research + Innovation, and he's the founder of the Cardiogenic Shock Working Group. bit.ly/3VPLdLb #TuftsMedicine #InnovatorsInHealthcare



🔥🔥🔥Kapur vs Kanwar Powerhouse Debate btw #CSWG juggernauts Navin Kapur @manreetkanwar #THT2025 Should #DanGerShock lead to Class 1 vs Class 2a rec guidelines? Dan Burkhoff MD PhD Jaime Hernandez-Montfort Jacob Abraham, MD A. Reshad Garan MD Khue Ton


Star fellow (Cardiology Fellowship Training at Tufts MC) and #cardionerd Rachel Goodman questions the utility of UOP in HF trials at #THT2025. Peter Natov, MD Navin Kapur


Wrapping up a big week for #cardiology research + innovation in Boston at #THT2025 Technology and Heart Failure Therapeutics conference. Thanks to the #TuftsMedicine team for sharing their expertise and driving meaningful discussions that will shape the future of care. Cardiovascular Research Foundation
